Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,188,010
+$393,487 QoQ
Shares Held
49,336
+74.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,222
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Obermeyer Wealth Partners holds $14,931,348 across 9 Drug Manufacturers - General names. PFE ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,201 | $3,098,687 | |
| 2 | ABBV |
AbbVie Inc.
|
10,832 | $2,725,764 | |
| 3 | AZN |
Astrazeneca PLC
|
11,635 | $2,206,228 | |
| 4 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 5 | AMGN |
Amgen Inc
|
3,986 | $1,443,410 | |
| 6 | PFE |
Pfizer Inc
This page
|
49,336 | $1,188,010 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,359 | $1,074,131 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,532 | $722,093 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,188,010 | 49,336 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $794,523 | 28,295 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $623,620 | 25,045 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $640,490 | 25,137 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $715,370 | 29,512 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $841,490 | 33,208 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $821,076 | 30,949 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $928,945 | 32,099 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $915,421 | 32,717 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $907,896 | 32,717 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,029,184 | 35,748 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,317,910 | 39,732 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,431,143 | 39,017 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,604,133 | 39,317 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,608,423 | 50,906 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,033,658 | 46,473 | Shares | Sole | 2022-12-09 | |
| 2022-06-30 | $1,905,673 | 36,347 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,786,582 | 34,510 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,986,264 | 33,637 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,393,911 | 32,409 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,267,139 | 32,358 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,107,840 | 30,578 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $753,463 | 20,469 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $647,937 | 17,655 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $503,776 | 15,406 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $283,445 | 8,684 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||